Latest Danaher News & Updates

See the latest news and media coverage for Danaher. We track all announcements, press releases, and industry mentions in real time, all in one place.

Danaher

Life sciences and diagnostics innovator

danaher.com

Headquarters: Washington, United States
Founded year: 1984
Company type: Public company
Number of employees: 50,000+

Last updated Today

Latest news about Danaher

In short: Danaher completed its $9.9 billion acquisition of Masimo Corporation and reported strong Q1 2026 earnings with $6.0 billion in revenue.

Company announcements

June 22 Danaher

Danaher announces Q2 2026 earnings conference call

The webcast will take place on July 21, 2026, at 8 a.m. ET, discussing financial performance and future expectations.

June 10 Danaher

Danaher completes acquisition of Masimo Corporation

Masimo becomes a wholly-owned subsidiary, operating under its brand within Danaher's Diagnostics segment, strengthening acute care diagnostics with pulse oximetry and AI monitoring.

April 22 Danaher

Danaher announces pricing of euro-denominated senior notes

It will raise about €2.98 billion to help fund the Masimo acquisition and for general corporate purposes. The offering is expected to close on 2026-04-29.

April 21 Danaher

Danaher reports Q1 2026 results

Net earnings reach $1.0B, revenues grow 3.5% to $6.0B, adjusted EPS up 9.5%. Announces intent to acquire Masimo. Raises full-year guidance.

Media coverage

June 22 Orange County Business Journal

Danaher Finalizes $9.9B Purchase of Masimo

Katie Szyman posted on social media that she'd be stepping down as CEO of Masimo following the close of the acquisition Danaher Corp.'s $9.9 billion...

June 15 Yahoo Finance

Danaher Corporation’s (DHR) Recovery Fell Short of Investor Expectations

Madison Investments, an investment advisor, released its first-quarter 2026 investor letter for the “Madison Large Cap Fund”.

June 12 The Scientist

Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics

The Danaher company expands its collaboration with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 NMR in non-small cell lung cancer...

June 11 Yahoo Finance

Strong Performance Continues at DHR s Biotechnology Unit: What s Next?

Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders...

Never miss news about Danaher

Track Danaher and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.